AU2020240108B2 - Capsules and capsule coatings for gastric residence dosage forms - Google Patents

Capsules and capsule coatings for gastric residence dosage forms

Info

Publication number
AU2020240108B2
AU2020240108B2 AU2020240108A AU2020240108A AU2020240108B2 AU 2020240108 B2 AU2020240108 B2 AU 2020240108B2 AU 2020240108 A AU2020240108 A AU 2020240108A AU 2020240108 A AU2020240108 A AU 2020240108A AU 2020240108 B2 AU2020240108 B2 AU 2020240108B2
Authority
AU
Australia
Prior art keywords
gastric residence
dosage form
less
capsule
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020240108A
Other languages
English (en)
Other versions
AU2020240108A1 (en
Inventor
David Altreuter
Nupura BHISE
Megan BISHOFF
Sonia HOLAR
Erick PEEKE
Marlene Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nortiva Bio Inc
Original Assignee
Nortiva Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nortiva Bio Inc filed Critical Nortiva Bio Inc
Publication of AU2020240108A1 publication Critical patent/AU2020240108A1/en
Application granted granted Critical
Publication of AU2020240108B2 publication Critical patent/AU2020240108B2/en
Assigned to Nortiva Bio, Inc. reassignment Nortiva Bio, Inc. Request for Assignment Assignors: LYNDRA THERAPEUTICS, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
AU2020240108A 2019-03-20 2020-03-19 Capsules and capsule coatings for gastric residence dosage forms Active AU2020240108B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962821352P 2019-03-20 2019-03-20
US62/821,352 2019-03-20
PCT/US2020/023704 WO2020191229A1 (en) 2019-03-20 2020-03-19 Capsules and capsule coatings for gastric residence dosage forms

Publications (2)

Publication Number Publication Date
AU2020240108A1 AU2020240108A1 (en) 2021-11-11
AU2020240108B2 true AU2020240108B2 (en) 2025-12-04

Family

ID=72519175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020240108A Active AU2020240108B2 (en) 2019-03-20 2020-03-19 Capsules and capsule coatings for gastric residence dosage forms

Country Status (10)

Country Link
US (2) US12447130B2 (cg-RX-API-DMAC7.html)
EP (1) EP3941445A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022525926A (cg-RX-API-DMAC7.html)
CN (2) CN113966216A (cg-RX-API-DMAC7.html)
AU (1) AU2020240108B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021018496A2 (cg-RX-API-DMAC7.html)
CA (1) CA3134049A1 (cg-RX-API-DMAC7.html)
IL (1) IL286512B2 (cg-RX-API-DMAC7.html)
MX (2) MX429213B (cg-RX-API-DMAC7.html)
WO (1) WO2020191229A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
IL286512B2 (en) 2019-03-20 2026-03-01 Lyndra Therapeutics Inc Capsules and capsule coatings for stomach-retaining dosage forms
CN113840596A (zh) 2019-03-20 2021-12-24 林德拉治疗公司 用于胃滞留剂型的衣层
CN116234540A (zh) 2020-07-29 2023-06-06 赛康特集团有限责任公司 具有包括交联聚(癸二酸甘油酯)的结构的形状引导控释和滞留
EP4565274A2 (en) * 2022-08-03 2025-06-11 Lyndra Therapeutics, Inc. Metal cores for gastric residence systems

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080206145A1 (en) * 2005-01-06 2008-08-28 Michel Afargan Gastro-Retentive Diagnostic Assemblies
US20090304768A1 (en) * 2006-02-15 2009-12-10 Intec Pharma Ltd Gastro-Retentive System for the Delivery of Macromolecules
WO2010064100A1 (en) * 2008-12-04 2010-06-10 Intec Pharma Ltd. Baclofen gastroretentive drug delivery system
WO2010128495A1 (en) * 2009-05-07 2010-11-11 Rainbow Medical Ltd. Gastroretentive duodenal pill
WO2011048494A2 (en) * 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
WO2018102799A1 (en) * 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system
US20190070143A1 (en) * 2015-06-17 2019-03-07 Biogen Ma Inc. Dimethyl fumarate particles and pharmaceutical compositions thereof

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706149D0 (en) 1997-03-25 1997-05-14 Scherer Corp R P Comestible capsules having flavoured coatings
US20050064027A1 (en) * 2001-12-15 2005-03-24 Spherics, Inc. Bioadhesive drug delivery system with enhanced gastric retention
PT1578350E (pt) 2002-03-26 2009-08-27 Euro Celtique Sa Composições revestidas com geles de libertação constante
CN101232868A (zh) 2005-04-19 2008-07-30 阿尔扎公司 曲马多和加巴喷丁的控释递药剂型
EP1901721A1 (en) * 2005-06-23 2008-03-26 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
JP4948828B2 (ja) 2005-11-28 2012-06-06 森下仁丹株式会社 胃内浮遊滞留シームレスカプセルとその製造方法
JP2009523175A (ja) 2006-01-10 2009-06-18 パイペックス,インコーポレイテッド 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法
DK2997953T3 (en) 2006-01-18 2019-04-15 Intec Pharma Ltd ADMINISTRATION ORAL ADMINISTRATION
KR20110042366A (ko) 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
US8006033B2 (en) 2008-09-09 2011-08-23 Intel Corporation Systems, methods, and apparatuses for in-band data mask bit transmission
US20100286628A1 (en) * 2009-05-07 2010-11-11 Rainbow Medical Ltd Gastric anchor
CN103402502A (zh) 2011-02-14 2013-11-20 宝洁公司 包衣中包含蜂蜜的膜包衣固体剂型
EP3459570B1 (en) 2012-08-29 2021-03-10 Cardiac Pacemakers, Inc. Enhanced low friction coating for medical leads and methods of making
US10485758B2 (en) 2014-06-02 2019-11-26 Clexio Biosciences Ltd. Expandable gastroretentive dosage form
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
MX2016016406A (es) 2014-06-11 2017-10-12 Massachusetts Inst Technology Estructuras de permanencia, y métodos relacionados.
WO2015195989A1 (en) 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
WO2016178971A1 (en) 2015-05-01 2016-11-10 Massachusetts Institute Of Technology Triggerable shape memory induction devices
JPWO2017022248A1 (ja) * 2015-08-04 2018-05-24 富士カプセル株式会社 腸溶性カプセル
AU2016342374B2 (en) 2015-10-23 2022-08-04 Nortiva Bio, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
KR102796240B1 (ko) 2015-12-08 2025-04-16 린드라 테라퓨틱스 인코퍼레이티드 위 체류 시스템을 위한 기하 구성형태
US12109305B2 (en) 2016-05-27 2024-10-08 Lyndra Therapeutics, Inc. Materials architecture for gastric residence systems
EP3518902A4 (en) * 2016-09-30 2020-07-08 Lyndra, Inc. GASTRIC RESIDENCE SYSTEMS FOR LONG-TERM ADMINISTRATION OF ADAMANTANE CLASS MEDICINES
TWI811221B (zh) 2017-06-09 2023-08-11 美商萊恩卓治療公司 具有釋放速率調節膜之胃的滯留系統
JP7288435B2 (ja) 2017-09-20 2023-06-07 リンドラ セラピューティクス, インコーポレイティド 胃内滞留システムのカプセル封入
JP7394775B2 (ja) * 2017-11-28 2023-12-08 マサチューセッツ インスティテュート オブ テクノロジー 胃滞在電子機器
CA3118056A1 (en) 2018-08-15 2020-02-20 Lyndra, Inc. Systems for enteric delivery of therapeutic agents
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
IL286512B2 (en) 2019-03-20 2026-03-01 Lyndra Therapeutics Inc Capsules and capsule coatings for stomach-retaining dosage forms
CN113840596A (zh) 2019-03-20 2021-12-24 林德拉治疗公司 用于胃滞留剂型的衣层
CA3160665A1 (en) 2019-11-08 2021-05-14 Lyndra Therapeutics, Inc. Gastric residence systems for administration of active agents
IL292848A (en) 2019-11-08 2022-07-01 Lyndra Therapeutics Inc Polymeric links for the gastric retention system
WO2021092486A1 (en) 2019-11-08 2021-05-14 Lyndra, Inc. Formulations for release-rate modulating films for gastric residence systems
EP4054538A4 (en) 2019-11-08 2024-02-07 Lyndra Therapeutics, Inc. STOMACH RESIDENCE SYSTEMS WITH A FILAMENT FOR IMPROVED STOMACH RESIDENCE
WO2021092484A1 (en) 2019-11-08 2021-05-14 Lyndra, Inc. Gastric residence systems having arms with controlled stiffness for improved gastric residence
JP2024503485A (ja) 2021-01-19 2024-01-25 リンドラ セラピューティクス, インコーポレイティド リスペリドンを投与するための胃内滞留システム
EP4333823A4 (en) 2021-05-05 2025-04-09 Lyndra Therapeutics, Inc. Indwelling gastric sytems containing buprenorphine and naloxone
AU2022270208A1 (en) 2021-05-05 2023-12-07 Lyndra Therapeutics, Inc. Gastric residence systems comprising methadone
IL314378A (en) 2022-01-19 2024-09-01 Lyndra Therapeutics Inc Dosage forms for gastric preservation
EP4565274A2 (en) 2022-08-03 2025-06-11 Lyndra Therapeutics, Inc. Metal cores for gastric residence systems
JP2025531626A (ja) 2022-09-30 2025-09-22 リンドラ セラピューティクス, インコーポレイティド 胃内滞留システムを用いたリスペリドンの投与レジメン
WO2024249946A2 (en) 2023-06-02 2024-12-05 Lyndra Therapeutics, Inc. Manufacturing methods for gastric residence systems

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080206145A1 (en) * 2005-01-06 2008-08-28 Michel Afargan Gastro-Retentive Diagnostic Assemblies
US20090304768A1 (en) * 2006-02-15 2009-12-10 Intec Pharma Ltd Gastro-Retentive System for the Delivery of Macromolecules
WO2010064100A1 (en) * 2008-12-04 2010-06-10 Intec Pharma Ltd. Baclofen gastroretentive drug delivery system
WO2010128495A1 (en) * 2009-05-07 2010-11-11 Rainbow Medical Ltd. Gastroretentive duodenal pill
WO2011048494A2 (en) * 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
US20190070143A1 (en) * 2015-06-17 2019-03-07 Biogen Ma Inc. Dimethyl fumarate particles and pharmaceutical compositions thereof
WO2018102799A1 (en) * 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system

Also Published As

Publication number Publication date
EP3941445A1 (en) 2022-01-26
US20250332111A1 (en) 2025-10-30
MX429213B (es) 2025-11-13
IL286512B2 (en) 2026-03-01
US20220160642A1 (en) 2022-05-26
MX2025012985A (es) 2025-12-01
JP2022525926A (ja) 2022-05-20
IL286512A (en) 2021-10-31
EP3941445A4 (en) 2023-08-02
MX2021011314A (es) 2021-12-10
US12447130B2 (en) 2025-10-21
IL286512B1 (en) 2025-11-01
AU2020240108A1 (en) 2021-11-11
BR112021018496A2 (pt) 2021-11-30
CA3134049A1 (en) 2020-09-24
JP2025066761A (ja) 2025-04-23
CN119033720A (zh) 2024-11-29
WO2020191229A1 (en) 2020-09-24
CN113966216A (zh) 2022-01-21

Similar Documents

Publication Publication Date Title
US20250332111A1 (en) Capsules and capsule coatings for gastric residence dosage forms
AU2020242062B2 (en) Coatings for gastric residence dosage forms
JP2022525926A5 (cg-RX-API-DMAC7.html)
RU2428176C2 (ru) Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты
CA2606813C (en) Timed, pulsatile release systems
EP2844296B1 (en) Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
CA2637655C (en) Method and apparatus for forming delivery devices for oral intake of an agent
JP2022525482A5 (cg-RX-API-DMAC7.html)
JP2004513913A (ja) 持続放出性抗高血糖薬マイクロカプセルに基づく薬剤およびその調製方法
CN101686947A (zh) 度洛西汀制剂
HK40066247B (en) Coatings for gastric residence dosage forms
HK40066247A (en) Coatings for gastric residence dosage forms
CN118829419A (zh) 含有大环内酯类免疫抑制剂的经粘膜治疗系统
AU2013273835B2 (en) Timed, pulsatile release systems

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: NORTIVA BIO, INC.

Free format text: FORMER APPLICANT(S): LYNDRA THERAPEUTICS, INC.

FGA Letters patent sealed or granted (standard patent)